BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20732796)

  • 21. Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres.
    Gupte A; Ciftci K
    Int J Pharm; 2004 May; 276(1-2):93-106. PubMed ID: 15113618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the drug-polymer interaction in calcium alginate beads containing diflunisal.
    Mandal B; Alexander KS; Riga AT
    Pharmazie; 2010 Feb; 65(2):106-9. PubMed ID: 20225653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and biological evaluation of paclitaxel-loaded poly(L-lactic acid) microparticles prepared by supercritical CO2.
    Kang Y; Wu J; Yin G; Huang Z; Liao X; Yao Y; Ouyang P; Wang H; Yang Q
    Langmuir; 2008 Jul; 24(14):7432-41. PubMed ID: 18547089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice.
    Harper E; Dang W; Lapidus RG; Garver RI
    Clin Cancer Res; 1999 Dec; 5(12):4242-8. PubMed ID: 10632366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations.
    Nsereko S; Amiji M
    Biomaterials; 2002 Jul; 23(13):2723-31. PubMed ID: 12059022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel-octreotide conjugates inhibit growth of human non-small cell lung cancer cells in vitro.
    Sun ML; Wei JM; Wang XW; Li L; Wang P; Li M; Yi CH
    Exp Oncol; 2007 Sep; 29(3):186-91. PubMed ID: 18004242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alginate microparticles as novel carrier for oral insulin delivery.
    Reis CP; Ribeiro AJ; Neufeld RJ; Veiga F
    Biotechnol Bioeng; 2007 Apr; 96(5):977-89. PubMed ID: 17001630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
    Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
    Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
    Derakhshandeh K; Erfan M; Dadashzadeh S
    Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Budesonide/cyclodextrin complex-loaded lyophilized microparticles for intranasal application.
    Kim JE; Cho HJ; Kim DD
    Drug Dev Ind Pharm; 2014 Jun; 40(6):743-8. PubMed ID: 23547762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, characterization and properties of partially hydrolyzed ethylene vinyl acetate copolymer films for controlled drug release.
    Tang M; Hou J; Lei L; Liu X; Guo S; Wang Z; Chen K
    Int J Pharm; 2010 Nov; 400(1-2):66-73. PubMed ID: 20804834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of local tumor growth with paclitaxel-loaded microspheres.
    Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of essential oil in alginate microparticles by multiple emulsion/ionic gelation process.
    Hosseini SM; Hosseini H; Mohammadifar MA; Mortazavian AM; Mohammadi A; Khosravi-Darani K; Shojaee-Aliabadi S; Dehghan S; Khaksar R
    Int J Biol Macromol; 2013 Nov; 62():582-8. PubMed ID: 24120881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-step bulk preparation of calcium carbonate nanotubes and its application in anticancer drug delivery.
    Tang J; Sun DM; Qian WY; Zhu RR; Sun XY; Wang WR; Li K; Wang SL
    Biol Trace Elem Res; 2012 Jun; 147(1-3):408-17. PubMed ID: 22351100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of anti-tumor efficacy of paclitaxel delivered in nano- and microparticles.
    Chakravarthi SS; De S; Miller DW; Robinson DH
    Int J Pharm; 2010 Jan; 383(1-2):37-44. PubMed ID: 19747969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodegradable microparticles and fiber fabrics for sustained delivery of cisplatin to treat C6 glioma in vitro.
    Xie J; Tan RS; Wang CH
    J Biomed Mater Res A; 2008 Jun; 85(4):897-908. PubMed ID: 17896769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.